Chemicals in food 2016 Overview of selected data collection

| September 14, 2017

article image
Pesticide residues in vegetables? Contaminants in palm oil? Traces of veterinary medicines in meat? This report provides an overview of data collected by EU Member States and analysed by EFSA in 2015 and 2016 to monitor chemicals in food and help protect consumers. Why are there chemicals in our food? Chemicals are essential building blocks for practically everything, including people, animals, plants – and food. The chemicals in our food are largely harmless and often desirable. Just think of nutrients like carbohydrates, protein, fat and fibre, which are made up of chemical compounds. These chemicals contribute both to a rounded diet and to our eating experience. Some chemical substances occur naturally in the food chain, others as a result of, for example, farming, food processing and transportation.

Spotlight

Juno Therapeutics, Inc.

Juno Therapeutics is building a fully integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Founded on the vision that the use of human cells as therapeutic entities will drive one of the next important phases in medicine, Juno is developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as solid tumors. Several product candidates have shown compelling evidence of tumor shrinkage in clinical trials in refractory leukemia and lymphoma conducted to date.

OTHER ARTICLES

Guyana-Suriname basin: Rise from obscurity to super potential

Article | May 13, 2021

Recent discoveries in the Guyana-Suriname basin attest to estimates of 10+ Bbbl of oil resources and more than 30 Tcf of gas.1 Like many oil & gas successes, this is a story that begins with early exploration success onshore, followed by a long period of exploration disappointment in coastal to shelf regions offshore, eventually culminating in deepwater success.

Read More

Improving 3D Chemical Visualization of Subsurface Structures

Article | February 19, 2020

A Raman microscope combines a Raman spectrograph and a light microscope to gain chemical and structural information from materials down to the micron scale. Raman spectroscopy observes when the wavelength of light changes as it interacts with a molecule. The different wavelengths seen in Raman scattering can identify and study vibrational, rotational, and bending forces within chemical bonds of a molecule.

Read More

What's the Most Toxic Chemical?

Article | February 24, 2020

People say America doesn’t make things anymore. But what about toxic chemicals? We make so many of those, we throw half of them in rivers, for free. The problem is, it can be hard to get a handle on which of those chemicals are extremely toxic and which of them are merely somewhat toxic. If one or another shows up in a scan of your stomach, should you freak out or just be grateful it wasn’t something worse? For this week’s Giz Asks, we reached out to a number of experts to find out what the most toxic chemical is.

Read More

THE BUSINESS CASE FOR SUSTAINABILITY IN THE CHEMICAL INDUSTRY IN 2020 & BEYOND

Article | March 3, 2020

Sustainability fervor – which has been building in importance over the past few years – has reached a new height in 2020. Chemical industry leaders made lofty statements at the World Economic Forum in Davos about the importance of engaging in sustainable development. Despite that, the chemicals industry is big, conservative, and typically slow to move. This raises the question: "What factors will really force change in the chemicals industry, and what does that change look like?" In this blog, we examine three possible drivers of change – carbon taxes, investor pressure, and supply chain pressure – and discuss their possible implications. We specifically focus on chemical companies, as highly carbon-intensive industries like cement and steel face a very different picture with respect to sustainability challenges.

Read More

Spotlight

Juno Therapeutics, Inc.

Juno Therapeutics is building a fully integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Founded on the vision that the use of human cells as therapeutic entities will drive one of the next important phases in medicine, Juno is developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as solid tumors. Several product candidates have shown compelling evidence of tumor shrinkage in clinical trials in refractory leukemia and lymphoma conducted to date.

Events